Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Open-label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Minor Surgical Procedures

NCT00209560 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00209560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00209560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Open-label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Minor Surgical Procedures
Lead sponsor
Eisai Inc.
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 2004
Completion date
March 31, 2005
Enrollment
168 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arthroscopy, bunionectomy, carpal tunnel, osteotomy